Gyre Therapeutics acquires Cullgen
Gyre Therapeutics agreed to acquire Cullgen. Reported deal value: Undisclosed. Status: Announced. Sector: Biotechnology. Target headquarters context: San Diego, California, United States.
This page summarizes publicly available information about the transaction as of 2026-03-02. Figures and status may change as filings and press coverage update.
Gyre Therapeutics enters into agreement to acquire Cullgen to gain targeted protein degradation platform and pipeline Gyre Therapeutics Inc: Gyre Therapeutics enters into agreement to acquire Cullgen to gain Targeted Protein Degradation Platform and pipeline Gyre Therapeutics Inc: all-stock transaction valued
Deal timeline
This transaction is classified in Biotechnology. Figures and status may change as sources update.